Is guanfacine effective in treating ADHD in children?

Guanfacine is a selectiveα2A-adrenergic receptor agonist. In recent years, it has been used in children with attention deficit hyperactivity disorder (ADHD, especially in children who are intolerant to traditional central stimulants (such as methylphenidate, amphetamine drugs) or who are accompanied by impulse control disorders, anxiety, and sleep problems. Guanfacine does not improve attention by stimulating the nervous system, but by reducing norepinephrine release and regulating neural activity in the prefrontal cortex, thereby helping to improve attention, alleviate impulsive behavior, and improve anxiety and irritability.

Multiple clinical practices and international guidelines recommend guanfacine as a second-line or combined treatment for ADHD, especially when traditional drugs are ineffective or have significant side effects. Compared with stimulant drugs, guanfacine has a slightly slower onset of action and generally requires continuous use for several weeks to see significant effects. However, it is milder and more stable in terms of behavioral management and improvement of aggressive behavior. Some research and practical feedback point out that guanfacine is particularly effective in improving sleep disorders, extending sleep time and improving overall sleep quality. This is particularly important for children with ADHD who are prone to insomnia or have sleep disorders caused by stimulant drugs.

In terms of tolerability, guanfacine has fewer overall side effects. Common adverse reactions include drowsiness, fatigue, hypotension, dizziness, etc. Some patients will experience mild bradycardia in the early stages, but most symptoms will gradually ease as the medication is prolonged. To minimize side effects, doctors usually recommend starting with a low dose and gradually titrating to the appropriate dose. It should be noted that guanfacine should not be stopped suddenly. It is recommended to gradually reduce the dose under the guidance of a doctor to avoid rebound hypertension or other uncomfortable reactions.

Reference materials:https://go.drugbank.com/drugs/DB01018